Welcome to a gateway featuring some of the latest most comprehensive information concerning the treatment and management of cancer today.
This year approximately 1,255,000 people are expected to be diagnosed with cancer (excluding non-invasive skin cancers). While cure rates differ dramatically by cancer type and staging, surgery, chemotherapy and radiation will effectively bring about long-term cures for about 55% of cancer patients.
Unfortunately, cancer cells do not present an attractive target for intervention and 45% of patients will eventually succumb to their disease.
The information found in this website is primarily directed towards those patients who have been given poor prognosis and their medical oncologist who have run out of treatment options. At a recent meeting, in Amsterdam, Netherlands, which was sponsored by the National Cancer Institute and the European Organization for Research in Treating Cancer, cautious hope emerged. A revolutionary new view of treatment protocols was put forth.
“Imagine cancer as like an infection or chronic disease where patients can live long times with therapy that’s tolerable,” said Dr. Lee Rosen, a cancer researcher at UCLA. “While we should all work toward the cure for cancer, I would be very satisfied if I could look a patient in the eye and say, ‘I can keep you alive for thirty years with something that doesn’t make you lose your hair or make you nauseated …and give a good quality of life.”
In an attempt to achieve that goal, we will focus on two separate protocols, both employing an anti-angiogenic approach to control cancer while maintaining good quality of life.
Disclaimer: The data provided in this site does not constitute medical advice, and is for information and education purposes only. Please consult your physician for specific treatment recommendations. All medical and therapeutic decisions must come from you and your physician.
For current and updated research for the ingredients used in this protocol, direct your attention to Bill’s Blog/Updated Research page.